David Phillips - 12 Jan 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 12 Jan 2022
Net transaction value: +$139,050
SEC form: 4
Accepted by SEC: 14 Jan 2022, 07:09:33 UTC
Source filing: View source filing
Reporting owner signature: David Phillips

Key filing fact

David Phillips filed Form 4 for MERIDIAN BIOSCIENCE INC on 14 Jan 2022.

Key facts

This page summarizes David Phillips's Form 4 filing for MERIDIAN BIOSCIENCE INC.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jan 2022, 07:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$139,050.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIVO transaction

Common Stock

Options Exercise

Transaction value: $139,050
Shares: +7,500
Change %: +115%
Price: $18.54
Shares after: 14,045
Date: 12 Jan 2022
Ownership: Direct

VIVO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 52,293
Date: 12 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIVO transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 12 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $18.54
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are held in the David C. Phillips Trust, of which the reporting person is the sole trustee.

Footnote F2

This award vested 25% every 90 days from the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .